Georgi Z.
- Country
- Bulgaria
- Department
- Clinic of Medical Oncology
Research Overview
- Phase III Randomized Double-Blind Study of Alpelisib and Fulvestrant in HR-Positive, HER2-Negative Advanced Breast Cancer with PIK3CA Mutation
- Evaluation of Patient Preference for Home Administration of Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab in HER2-Positive Breast Cancer
- Continuation Study of Olaparib in Patients with BRCA-Mutated Ovarian, Metastatic Breast, Pancreatic, Prostate, and Endometrial Cancers
Data & Insights
Has run more than one trial at 14 of 124 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in treating hormone receptor-positive and HER2-positive breast cancer, with particular focus on advanced and metastatic cases. Their expertise extends to novel therapeutic combinations including alpelisib with fulvestrant and innovative approaches using pertuzumab-trastuzumab combinations.
- Advanced HR-positive breast cancer management
- HER2-positive breast cancer treatment
- Subcutaneous administration approaches
Oncology Therapeutics
The investigator has extensive experience in treating various forms of cancer using targeted therapies. Their work encompasses BRCA-mutated cancers and the application of olaparib-based treatments across multiple cancer types including ovarian, pancreatic, prostate, and endometrial cancers.
- BRCA mutation targeted therapies
- Multiple cancer type management
- Continuous treatment strategies
Head and Neck Cancer
The investigator focuses on treating recurrent and metastatic head and neck squamous cell carcinoma. Their research includes innovative combination approaches using zanzalintinib with pembrolizumab and immunotherapy-based treatments.
- Squamous cell carcinoma treatment
- Immunotherapy combinations
- Advanced disease management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.